Cboe US - Delayed Quote USD

ARK Genomic Revolution ETF (ARKG)

25.33 +0.43 (+1.73%)
At close: September 11 at 4:00 PM EDT
25.35 +0.02 (+0.08%)
Pre-Market: 6:50 AM EDT
Loading Chart for ARKG
DELL
  • Previous Close 24.90
  • Open 24.78
  • Bid 25.33 x 1000
  • Ask --
  • Day's Range 24.51 - 25.35
  • 52 Week Range 21.97 - 34.37
  • Volume 2,401,100
  • Avg. Volume 2,345,179
  • Net Assets 1.37B
  • NAV 25.32
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return -22.80%
  • Beta (5Y Monthly) 1.78
  • Expense Ratio (net) 0.75%

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

ARK ETF Trust

Fund Family

Health

Fund Category

1.37B

Net Assets

2014-10-31

Inception Date

Performance Overview: ARKG

View More

Trailing returns as of 9/11/2024. Category is Health.

YTD Return

ARKG
22.80%
Category
12.21%
?

1-Year Return

ARKG
19.77%
Category
16.25%
?

3-Year Return

ARKG
32.73%
Category
1.82%
?

People Also Watch

Holdings: ARKG

View More

Top 10 Holdings (53.74% of Total Assets)

SymbolCompany% Assets
TWST
Twist Bioscience Corporation 8.28%
CDNA
CareDx, Inc 6.89%
RXRX
Recursion Pharmaceuticals, Inc. 6.47%
CRSP
CRISPR Therapeutics AG 6.06%
NTLA
Intellia Therapeutics, Inc. 5.03%
IONS
Ionis Pharmaceuticals, Inc. 4.81%
VCYT
Veracyte, Inc. 4.17%
TXG
10x Genomics, Inc. 4.16%
NRIX
Nurix Therapeutics, Inc. 3.99%
ADPT
Adaptive Biotechnologies Corporation 3.90%

Sector Weightings

Recent News: ARKG

View More

Research Reports: ARKG

View More

Related Tickers